Published in
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature, 2018
DOI: 10.3410/f.734064972.793551288
Links
Tools
Faculty Opinions recommendation of Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma.
Dataset published in 2018 by
Jos van der Hage 
